ÂÜÀòÂÒÂ×

Dr. Sean Bohen was executive vice president of global medicines development and chief medical officer at AstraZeneca from 2015 to 2019. He was responsible for AstraZeneca’s worldwide product development and clinical programs to address unmet medical needs and renew AstraZeneca's product pipeline. Prior to joining AstraZeneca, he was Senior Vice President of Genentech Early Development from January, 2011. Dr. Bohen’s career at Genentech spanned 12 years. He joined Genentech in 2003 as Assistant Medical Director, Rituxan Heme/Onc. He was Associate Medical Director of Oncology Exploratory Clinical Development in 2004 and became Medical Director in 2005, then Associate Director in April, 2006. In October, 2006, he was Director of ITGR Exploratory Clinical Development and was promoted to Senior Director in October, 2007, then to Vice President of Immunology Development in August, 2008. In addition, Dr. Bohen also was an Adjunct Clinical Instructor in Oncology at Stanford University School of Medicine from 2002 to 2011. He received his Bachelor of Science (Bacteriology) from University of Wisconsin-Madison, and M.D. and Ph.D. in Biochemistry from University of California, San Francisco.